In this article, we are going to take a look at where Absci (NASDAQ:ABSI) stands against other AI companies under $2 billion market cap. It’s clear that AI holds immense promise but it comes ...

ABS-101 appears to be ABSI’s main drug candidate for IBD. However, ABS-201 for hair loss and ABS-301 for solid tumors offer additional sizeable TAMs if successful. ABSI’s AI models and wet lab ...

Absci (NASDAQ:ABSI) was rising after a media report on a $20M investment by the semiconductor company Advanced Micro Devices (NASDAQ:AMD) in the AI drug creation company. ABSI is trading +43.97% ...

Get Wall Street's Hottest Chart Every Morning Needham analyst has initiated coverage on Absci Corporation ABSI, a drug and target discovery company that harnesses deep learning AI and synthetic ...

Price Action: ABSI shares are trading higher by 44.3% at $4.46 in premarket at the last check Wednesday. Read Next : AMD and Nvidia Overtake Intel in Key Markets, Challenging Its Leadership ...